ABILITY PHARMACEUTICALS
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
ABILITY PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.abilitypharma.com
Total Employee:
1+
Status:
Active
Contact:
+34 935 86 89 77
Email Addresses:
[email protected]
Total Funding:
19.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Font Awesome Apache Euro IPv6 Google Apps For Business
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Investors List
SciClone Pharmaceuticals
SciClone Pharmaceuticals investment in Corporate Round - Ability Pharmaceuticals
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - Ability Pharmaceuticals
Horizon 2020
Horizon 2020 investment in Grant - Ability Pharmaceuticals
European Innovation Council
European Innovation Council investment in Grant - Ability Pharmaceuticals
Inveready
Inveready investment in Venture Round - Ability Pharmaceuticals
Everis Group
Everis Group investment in Venture Round - Ability Pharmaceuticals
Capital Cell
Capital Cell investment in Venture Round - Ability Pharmaceuticals
Capital Cell
Capital Cell investment in Equity Crowdfunding - Ability Pharmaceuticals
Inveready
Inveready investment in Venture Round - Ability Pharmaceuticals
Official Site Inspections
http://www.abilitypharma.com
- Host name: hosting.twentic.com
- IP address: 178.33.116.190
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Ability Pharmaceuticals"
Ability Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +34 935 86 89 77; ... a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the …See details»
The Company - Ability Pharma
"We are committed to creating the future of oncology by developing innovative therapies inducing autophagy to address unmet medical needs"See details»
AbilityPharma - LinkedIn
AbilityPharma receives World Health Organization approval for its ABTL0812 anticancer drug to be named #IBRILATAZAR. ... AbilityPharma's is currently conducting, with ABTL0812, the …See details»
Management Team - Ability Pharma
Sep 9, 2024 Marc obtained his degree in Medicine and Surgery at the University of Barcelona in 1993. He started his medical activities as a volunteer at the refugee’s camps of the former YuSee details»
AbilityPharma - Biotech Careers
AbilityPharma is a clinical-stage biopharmaceutical company focused on developing fully differentiated oral targeted anticancer compounds that produce autophagy-mediated …See details»
Ability Pharmaceuticals - ASEBIO
AbilityPharma is a biopharmaceutical company focused on creating the future of oncology by developing innovative therapies that address unmet medical needs. Established in 2009 and …See details»
Ability Pharma (fka AB Therapeutics) | VentureRadar
AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class causing autophagy molecules through binding to the nuclear receptors PPARa/?. It represents …See details»
Overview, News & Similar companies - ZoomInfo.com
Dec 12, 2017 Who is Ability Pharmaceuticals. Ability Pharmaceuticals (www.abilitypharma.com) is a clinical-stage biopharmaceutical company focused on creating the future of oncology by …See details»
AbilityPharma - Company Profile - Tracxn
Dec 12, 2024 AbilityPharma. has raised a total funding of $14.5M over 6 rounds. Its first funding round was on Jan 01, 2010. What are the most recent funding rounds of AbilityPharma? Its …See details»
Ability Pharmaceuticals, SL - European Commission
Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space.See details»
Ability Pharma Company Profile 2024: Valuation, Funding
Information on valuation, funding, acquisitions, investors, and executives for Ability Pharma. Use the PitchBook Platform to explore the full profile.See details»
Operations and Strategy Team of Advisors - Ability Pharma
Jul 30, 2024 Dr. Ramesh is a Veterinarian, board-certified Regulatory Professional and board-certified Toxicologist & Pharmacologist with 18 years of pharmaceutical industry, GLP and non …See details»
Ability Pharma - Products, Competitors, Financials, Employees ...
In March 2024, Catalan biopharmaceutical company AbilityPharma has obtained a €7m ($7.65m) investment to advance its Phase IIb clinical trial of ABTL0812, an autophagy inducer aimed at …See details»
AbilityPharma Company Profile - Office Locations, Competitors
AbilityPharma has 5 employees across 2 locations. See insights on AbilityPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Ability Pharma (company) | Nordic 9
Ability Pharma (company). AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class causing autophagy molecules through binding to the nuclear …See details»
Ability Pharmaceuticals - Seedtable
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Ability Pharmaceuticals SL (Ability Pharmaceuticals SL) - 药物管线_ …
AbilityPharma is completing a Phase 2b clinical trial with ABTL0812 in metastatic pancreatic cancer (all 140 patients recruited) with the aim of demonstrating greater efficacy than standard …See details»
CSR - Ability Pharma
Jul 16, 2024 Ability Pharmaceuticals is an innovative and responsible company regarding the relationship with our stakeholders, suppliers, partners, institutions, employees, the …See details»
Ability Pharmaceuticals SL - Drug pipelines, Patents ... - Patsnap
AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer. ... The statistics for …See details»
Royalty Pharma simplifies corporate structure with $1.1 billion deal
10 hours ago (Reuters) -Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to …See details»